RBBP7 and inflammatory bowel disease: Furthermore, the therapeutic effect in CD was better than that in UC, indicating that IBD with high expression of some m6A phenotype-related hub genes (H2AFZ, NUP37, SNRPD1, CPSF3, and RBBP7) may represent those characterized by resistance to infliximab.